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Abstract
The goal of this thesis is to incorporate magnetic nanoparticles into nanogel systems to
offer targeted and sustained drug delivery across biological barriers in response to a magnetic
field in combination with magnetic imaging modality. Iron oxide magnetic nanoparticles were
incorporated into thermo-responsive and biodegradable nanogels containing poly(Nisopropylacrylamide), dextran and lactate or ε-caprolactone oligomers during the nanogel
synthesis by UV polymerization. The magnetization properties of the nanogels were measured
by using a vibrating sample magnetometer. The results showed that the obtained magnetic
nanogels were ferromagnetic, and the magnetization of nanogels increased with increasing the
amount of iron oxide magnetic nanoparticles in the nanogels from 0 to 15 wt%. The saturated
magnetization of the nanogels containing ε-caprolactone oligomers were two to four times higher
than that of the corresponding nanogels containing lactate oligomers. MTS tests showed that the
nanogels containing lactate or ε-caprolactone oligomers were not cytotoxic to NIH/3T3 at
concentration up to 5 and 0.625 mg·mL-1, respectively with cell viability above 80%. When 10
wt% iron oxide nanoparticles were incorporated into the nanogels, the cell viability was
increased. The successful completion of this project will have significant impact on long-lasting
magnetic-stimulus-responsive therapy and diagnosis for many diseases.
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Introduction
Nanoparticles are of great importance in biomedicine. Due to their ability to encapsulate
or conjugate to a large variety of molecules, nanoparticles have been extensively used in imaging
and drug delivery thanks to their robust versatility [1-3]. Nanoparticles can be designed to
control release of molecules in response to pH changes [4-6], temperature changes [7-11], the
redox potential change [12-14], light [15], ultrasound [16], and magnetic field stimuli ([17],
[18]). Magnetic field stimulus has been increasingly attractive for drug delivery and imaging due
to the ability to steer magnetic nanoparticles to target sites and tissues by using a high gradient
external magnet while retaining the ability to conjugate therapeutics peptides, and other
functional molecules [19, 20]. The alternation of the applied magnetic fields allows magnetic
nanoparticles to induce localized hyperthermia, giving it unique applications such as
temperature-responsive release mechanisms and thermoablation [21-23].
For biomedical applications, magnetic nanoparticles can be separated into two categories:
superparamagnetic and ferromagnetic nanoparticles. Superparamagnetic nanoparticles exhibit
magnetization when the magnetic field is applied and returns to the rest state without residual
magnetization once the magnetic field is removed [3, 24, 25]. These particles can generate heat
when an alternating magnetic field is applied due to the oscillation of the magnetic moments of
the magnetic field energy, making them good candidates for treatments such as hyperthermia and
thermoablation [26]. Materials that retain magnetization after the magnetic field is removed (a
hysteresis curve) are said to be ferromagnetic [27]. Ferromagnetic nanoparticles have similar
properties to superparamagnetic ones but exhibit trade-offs, generating more energy at the
expense of precise control of movement [28]. These nanoparticles have residual magnetization,
which generates higher amounts of energy and temperatures, leading to a greater effect on
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hyperthermia due to the continued movement after the applied magnetic field is removed [3].
The sizes of the two nanoparticle categories differ as well, with superparamagnetic nanoparticles
having maximum diameters at 20 nm, while ferromagnetic nanoparticles have diameters from 20
nm to 1mm [25]. Without shielding from the body's internal structures, both kinds of magnetic
nanoparticles tend to have increased clearance from the body, risk of protein absorption, and
aggregation [29]. Magnetic nanoparticles-encapsulated dendrimers [30-33], liposomes [34-36],
and micelles [37, 38] have been used for the controlled release of doxorubicin [31, 37], delivery
to the bone marrow [39], increased permeability into cells [30, 31, 36, 38], contrasts agents in
imaging [32, 33], [34, 35], and increased targeting in response to a magnetic field [30, 36]. While
these magnetic nanoparticle-encapsulated systems are good for targeting, imaging, and drug
delivery, they share the same limitations as their native nanosystems. For applications such as
ocular delivery, the systems used must avoid being cleared too quickly from the eye, allow for
cell-specific targeting, and have high permeability through ocular tissues [40, 41]. Magnetic
dendrimers cannot efficiently cross biological barriers [42], magnetic liposomes are easily
cleared by liver and spleen tissues [39], and magnetic micelles have problems with poor loading
efficiency and poor physical stability [38, 43].
Nanogels are physically or chemically crosslinked nanosized materials, which shows
promise to increase drug payload, help drugs to cross biological barriers, and decrease early drug
clearance [44, 45]. The crosslinking structure of nanogels allows the nanogels to swell and
release biological agents in a controlled manner [44, 46]. In addition, the structure of the
nanogels provides allows molecule incorporation via physical entrapment and covalent
conjugation [45]. When magnetic nanoparticles are incorporated into nanogels, the nanogels can
be used to release drugs and imaging contrasts in a more controlled way under an applied
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magnetic field and hyperthermia. Cazares-Coretes et al. [47] created thermoresponsive
oligo(ethylene glycol) methyl ether methacrylate-based magnetic nanogels that cumulatively
released over five times the amount of doxorubicin (µM) compared to unincorporated magnetic
nanoparticles in pH 7.5 solution, with and without exposure to an external magnetic field and
over double the amount of doxorubicin (µM) from 4 to 70 °C. Without damaging nearby cells,
the internal temperature of the nanogel was raised creating a temperature-sensitive response.
Similarly, polyethylene glycol (PEG) nanogels have been used in DNA and intracellular drug
delivery. Curcio et al. [48] used PEG magnetic nanogels to deliver siRNA to cancer cells and
found that the magnetic nanogel system lowered gene expression compared to untreated cells
and cells treated with siRNA only (55% downregulation efficiency vs. 0% ). Alginate nanogels
that incorporate magnetic nanoparticles have high storage stability and yield a similar response
to PEG magnetic nanogel, but have no sustained release [49]. When considering drug loading
efficiency, methylacrylic acid and polyacrylamide magnetic nanogels both have up to a 95%
loading efficiency but are most effective at pH 5.3, which is significantly lower than
physiological pH [49, 50]. For drug delivery to cartilage and bone, Fan et al. [51] developed a
chitosan-polyphosphate ester magnetic nanogel capable of efficiently delivering MP-2 to MG-63
human bone cells, substantially increasing cell viability. By incorporating magnetic nanoparticles
into the nanogel, Fan et al. found that the viability of human bone cells increased compared to a
nonmagnetic chitosan-polyphosphate ester nanogel in the presence of a magnetic field. Dextran
magnetic nanogel systems are capable of long-term stimulation by an alternating magnetic field
over several days. They were found to retain superparamagnetic properties and the same level of
magnetization as pure iron oxide nanoparticles for 5.71 wt% iron oxide nanogels [52, 53]. While
all these nanogels can have thermoresponsive properties or are capable of sustained release, very
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few are capable of long-term release past a couple of days, and none are capable of crossing
biological barriers. Our lab has developed thermoresponsive and biodegradable nanogels
containing poly(N-isopropylacrylamide), dextran and lactate oligomers (Figure 1) [54] that can
slowly release insulin for more than two months and enhance drug penetration across blood brain
and retinal barriers (data not shown). In this thesis work, magnetic particles were incorporated
into the thermo-responsive and biodegradable nanogels and tested for magnetization and
cytotoxicity to NIH/3T3 mouse fibroblast cells. The goal is to develop magnetic thermoresponsive and biodegradable nanogel systems that can offer targeted and sustained drug
delivery across biological barriers in response to a magnetic field in combination with magnetic
imaging modality to treat diseases. The central hypothesis of this research is that iron oxide
nanoparticles can be successfully incorporated into thermo-responsive and biodegradable
nanogel systems and the obtained magnetic nanogels have magnetic property and are
noncytotoxic.

Figure 1: Macromer and nanogel schemes of the Dex-lactate HEMA nanogels made by Huang
et al. comprised of a dextran chain, a methacrylate acid unit, and a lactate spacer. Reprinted with
permission.[54]
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Experimental Design and Methods
Materials
N- N-isopropylacrylamide (NIPAAM) and Irgacure 2959 were obtained from SigmaAldrich, Inc. (St. Louis, MO). Iron oxide nanoparticles of size 3 nm were obtained from US
Research Nanomaterials (Houston, TX). Dextran-polylactic acid- 2- hydroxyethyl methacrylate
(Dextran-PLA-HEMA) and dextran-polycaprolactone 2- hydroxyethyl methacrylate (dextranPCL-HEMA) macromers were synthesized by previous lab members in Dr. Lowe’s lab. Three(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) was obtained from Promega (Madison, WI). Deionized water (pH 5.4) was used
throughout the experiments.
Nanogel Synthesis and Iron Oxide Encapsulation
Nanogels were synthesized by photopolymerizing dextran-PLA-HEMA/ dextran-PCLHEMA macromer and NIPAAm at a 2:7 weight ratio with Irgacure 2959 as an initiator. In detail,
macromer and NIPAAm were dispersed in deionized water (10 mg·ml-1) and vortexed until the
solution was uniform. 0.05 wt% Irgacure was added to the above solution before
photopolymerization. The solution was degassed with N2 gas for 10 min. An EXFO Lite E3000
UV source (EXFO Inc., Richardson, Texas, USA) was used to provide UV radiation for the
photo-emulsion polymerization at 1000 mW·cm-2 for 15 min at 45 °C. Magnetic nanoparticle
incorporated nanogels were prepared by dispersing magnetic nanoparticles into the precursor
solution before UV polymerization. Iron oxide (IO) at 3 nm 5, 10, 15 wt% were incorporated
dispersed evenly throughout the nanogels with the unloaded nanogels being labeled 0 wt%
(base). The resulting nanogels (NDPLA and NDPCL) were dialyzed for 4 to 6 h in deionized
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water with water changes every half an hour. The nanogels were then dried for 72h using a
Labconco Console 6L lyopholizer (Kansas City, MI).
Vibrating Sample Magnetometer (VSM)
The magnetizations of the nanogels, NDPLA and NDPCL, with and without magnetic
nanoparticles were characterized by vibrating sample magnetometer (VSM, Dexing Magnet
Tech. Co. Ltmd. China). The samples analyzed were the nanogels alone and containing 5 and 15
wt% 3 nm iron oxide nanoparticles, and 3 nm iron oxide nanoparticles alone. Samples for the
VSM were created by taking approximately 10 to 20 mg of each nanogel and forming them into
small balls using cyanoacrylate in small amounts to maintain a uniform spherical shape for the
VSM. The continuous magnetic field (H) applied varied from -10,000 to 10,000 Oersted (Oe),
and the magnetization was measured in electromagnetic units·gram-1 (emu·g-1).
Due to the paramagnetic nature of the pure 3 nm iron oxide nanoparticles, a linear
relationship between the applied magnetic field (H) and the magnetization (M) of the materials
can be used to evaluate the nanogels [20]. χ, volumetric magnetic susceptibility, is the
propensity of a material to attract to or be repelled by the magnetic field, and M
(electromagnetic units per gram) is the magnetization of the material per unit volume. In cases
where the material is paramagnetic, the magnetic moments align with the H field (Oersted) and
give no hysteresis. When the magnetic moments remain after the removal of the H field, the
curve generated forms a hysteresis loop, and the material can be deemed as ferromagnetic. The
magnetization of the nanogels plotted the magnetization as a function of the H field, generating
M-H curves that were then compared to determine if the nanogels were
superparamagnetic/ferromagnetic and obtain the values of the saturation magnetization.
𝑀 = 𝜒𝐻 [20]
6

Cell Culture
NIH/3T3 mouse fibroblast cells were seeded in T75 flasks at a density of 28,000-30,000 cells
cm-2 and were cultured in Dulbecco’s Modified Eagle Medium (DMEM) containing 10% fetal
bovine serum (FBS) and L-glutamine at 37 C with 5% CO2. The medium was changed every two
to three days. The cells were harvested with trypsin (0.05%) when they were 80% confluent.
Cytotoxicity
A CellTiter 96. Aqueous One Solution Assay (Promega) was used to evaluate the cytotoxicity of
the nanogels to the NIH/3T3 mouse fibroblast cells. This assay uses MTS [3-(4,5dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium)] to
reduce in the presence of phenozine methosulfate located in the mitochondria of metabolically
active cells. When MTS is reduced, a colored dye is formed and can be read by a microplate
reader. While MTS assays measure cellular metabolic activity, there is a direct correlation
between cell viability and cell metabolism (r2=0.95) as living cells’ mitochondria generate the
reactive oxygen species needed to reduce the MTS compound [55, 56]. To evaluate cell viability,
NIH/3T3 mouse fibroblast cells were seed in 96 well plates at a density of 20,000 cells per well.
After incubating the cells in 150 µL DMEM with 10% FBS for 24 h at 37 C and 5% CO2, 100
µL medium was replaced with Dextran-lactate-HEMA nanogels (NDPLA and NDPCL)
dissolved in DMEM with 10% FBS. The cells were incubated for another 24 h at 37 C and 5%
CO2. After the second incubation, 25 µL MTS solution was added to each well, and the cell plate
was incubated for 45 min. The absorbance of the colored solutions was measured at a
wavelength of 490 nm using a microplate reader. Eight total gels were evaluated with this assay:
NDPLA 0, 5, 10, and 15 wt% IO and NDPCL 0, 5, 10, and 15 wt% IO. For every NDPLA and
NDPCL nanogel, 10, 5, 2.5, 1.25, 0.625, and 0.3125 mg·ml-1 concentrations were loaded in n= 2,
and 0 mg·ml-1 was loaded in n=5 to determine the cytotoxic effects of the concentration of the
7

nanogels and to evaluate the differences in cytotoxicity profiles between the NDPLA and
NDPCL nanogels as the percent iron oxide is increased. Wells with no NDPLA and NDPCL
nanogels were used as controls to establish baseline cytotoxicity.
Statistical analysis
As the sample size is small and not balanced (n=2 for six concentrations; n=5 for others),
Kruskal Wallis H tests (α=0.05) with Mann Whitney U tests were performed post hoc to
determine if the NDPLA and NDPCL formulations’ cytotoxicity were statistically significant for
each increase in the nanogels’ concentrations.
Results and Discussion
Magnetization
Magnetization-H field curves (M-H curves) from the VSM were evaluated for
saturation, and residual magnetization (Figure 2) with a 10 kOe H-field applied for every
sample. Pure IO nanoparticles (3 nm) were measured at 70.89 emu·g-1. The NDPCL nanogels
magnetizations (Figure 2) were measured at 3.00, 5.14, and 10.08 emu·g-1 for the 0, 5, and 15
wt% IO nanogels, respectively. The 0 and 15 wt% IO NDPLA nanogels (Figure 3) had
saturated magnetizations of 1.33 and 2.51 emu·g-1, respectively. The M-H curves were then
compared based on nanogel formulation used and IO wt%. For both NDPLA and NDPCL
nanogels, increasing the iron oxide concentration of the nanogels resulted in larger and more
paramagnetic hysteresis curves for the nanogels.
The magnetization of the 0 wt% IO nanogels gives the baseline magnetization of the
nanogel, so both NDPCL and NDPLA were evaluated to determine the effects of increasing
oxide content. As the concentration of iron oxide increased in the nanogel, both systems showed
an increase in magnetization. This result was in agreement with the literature showing that the
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concentration of superparamagnetic iron oxide nanoparticles in solution was correlated to an
increase in saturation magnetization [57]. The magnetization, however, can be impacted by the
material used to encapsulate the magnetic nanoparticles. As the NDPCL nanogels IO
concentration increased from 0 to 15 wt%, the overall magnetization increased by 7 emu·g-1. The
NDPLA nanogels made a smaller increase, with only a 1.18 emu·g-1 increase in magnetization.
Mandal et al. [58] synthesized iron oxide loaded NDPCL nanogels (13 wt%) that had a 10
emu·g-1 saturation magnetization, which indicated that the values obtained for the NDPCL
nanogels were close to what was expected for similar systems. There is currently no report on
iron oxide loaded PLA nanogel/hydrogel systems. However, the literature showed that PLA
tended to act as an insulator when electric and magnetic fields were applied [59] and inhibited
magnetization when used to coat magnetic nanoparticles [60, 61]. Despite not being comprised
of magnetic materials, NDPLA and NDPCL nanogels that do not contain iron oxide
nanoparticles have magnetic responsiveness (Figure 4). Polycaprolactone [58, 62, 63] and
polylactic acid [61, 64, 65] both have no inherent magnetism their respective chemical
backbones. Dextran [66], 2- hydroxyethyl methacrylate [67], and NIPAAM [68] are also
nonmagnetic materials. The VSM measurements indicate that both nanogel systems may have
inherent magnetic responsiveness that resembles ferromagnetic materials. Even though the
magnetization increases for both nanogel systems, the increase in magnetization suggests that
iron oxide-loaded NDPCL nanogels have over two times the intrinsic magnetization their
NDPLA counterparts have, even as the percent iron oxide is maintained between the two
materials. Both nanogels shield the magnetic nanoparticles from the applied field resulting in
lower magnetization values than the pure iron oxide nanogel. However, the difference between
the nanogel types could be attributed to polymer chemistry and size. While size was not
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measured for this experiment, previous NDPCL and NDPLA nanogels made by Janagam et al.
[69] have shown that the NDPCL nanogels tend to be smaller than the NDPLA, which would
give the magnetic fields less of a barrier to get through.
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Figure 2: NDPCL nanogels and pure iron oxide M-H curves. The M-H curve for the iron oxide
(labeled Pure IO 3-nm) shows the magnetization of the unencapsulated iron oxide nanoparticles.
The NDPCL nanogels (NG-PCL, MagNG-5NP-PCL, and MagNG-15NP-PCL) M-H curves
show the magnetization for the 0, 5, and 15 wt% IO NDPCL nanogels respectively.
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The NDPLA nanogels (NG-PLA and MagNG-15NP-PCL) M-H curves show the magnetization
for the 0 and 15 wt% IO NDPCL nanogels.
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Figure 4: NDPLA and NDPCL 0 wt% IO nanogels M-H comparison. NG-PCL 0% IO is the MH curve for the NDPCL nanogel, and NG-PLA 0% IO is the M-H curve for the NDPLA nanogel.
Cytotoxicity
The MTS assay measured the cytotoxicity of the NDPLA nanogels to the NIH/3T3 cells
as the nanogels’ concentrations increases. PCL nanogel cytotoxicity was also measured and
calculated at the same concentrations of IO and nanogel. As shown in Figure 5, 0 wt% IO
NDPLA nanogels were not cytotoxic to the cells at concentrations at or below 1.25 mg·ml-1. The
5 wt% IO NDPLA nanogels were not cytotoxic at the 0.31 and 0.625 mg·ml-1. The 10 wt% IO
NDPLA nanogels had cell viabilities above 80 % for all concentrations evaluated. The 15 wt%
IO nanogel was not cytotoxic at or below 2.5 mg·ml-1. As shown in Figure 6, NDPCL nanogels
were not cytotoxic at and below 0.625 mg·ml-1. The 0 wt% IO NDPCL nanogel was not
cytotoxic at the 0.31 mg·ml-1. The 10 and 15 wt% IO nanogels were not cytotoxic up to 0.625
mg·ml-1.
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Kruskal- Wallis H tests were performed on both the NDPLA and NDPCL cell viabilities to
determine if there were significant differences among the formulations for each nanogel
concentration. The cell viabilities for NDPLA nanogels were evaluated from 0.31 to 10 mg·ml-1.
The NDPCL nanogels were only assessed at 0.31 and 0.625 mg·ml-1, as all the NDPCL nanogels
were cytotoxic after 0.625 mg·ml-1. Mann Whitney U tests were performed post hoc to determine
the relationships between the nanogels better. As the iron oxide content for the nanogels
increased from 0 to 15 wt%, cell viability goes up with the max benefit being seen at 10 wt% IO.
As the nanogel concentration increases, the cell viability decreases across all nanogels.
Cell viabilities for the 0 and 15 wt% IO nanogels were higher than 5 wt% IO nanogels’
(p= 4.49*10-5 and p= 3.46*10-4), and 10 wt% IO nanogels had a higher cell viability than the
other IO concentrations at 0.3125 mg·ml-1 (p=0.005, p=0.02, and p=0.04 when compared to 0, 5,
and 15 wt% respectively). At 0.625 mg·ml-1, 10 and 15 wt% IO nanogels had larger cell
viabilities than the 0 and 5 wt% IO nanogels (p= 0.05 and p=0.01 for the 10 wt% and p= 0.03
and 0.01 for the 15 wt%). At 1.25 mg·ml-1, 0 wt% IO nanogels had greater cell viability than the
5 wt% IO nanogels (p=8.23*10-6), and the 10 and 15 wt% IO nanogels were less cytotoxic than
both the 0 and 5 wt% IO nanogels (p=0.01 and p=0.02 for the 10 wt% and p= 0.002 and p=0.01
for the 15 wt%). The 5 and 15 wt% IO nanogels were less cytotoxic than the 0 wt% nanogel at
the 2.5 mg·ml-1 (p=0.04 for the 5 wt% and p= 0.02 for the 15 wt%). At the same concentration,
10 wt% IO nanogels were less cytotoxic than the 0, 5, and 15 wt% IO nanogels (p=1.19*10-7, p
=0.04, p=0.03 respectively). For the nanogels at 5 mg·ml-1, 0 and 5 wt% IO nanogels were less
cytotoxic than the 15 wt% IO nanogels (p=0.001 and p=0.03), but were more cytotoxic than the
10 wt% IO nanogel (p=0.003, p=0.006, and p=0.02 from 0 to 15 wt%). At 10 mg·ml-1, the 10
wt% IO nanogels had greater cell viability than 0, 5, and 15 wt% IO nanogels (p=0.02, p=0.02,
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and p=0.03 respectively). For NDPCL nanogels, the Kruskal Wallis H test showed that the
different IO nanogels’ had statistically different cell viabilities for both the 0.31 and 0.625
mg·ml-1 concentrations (p=0.03 for both concentrations). Cytotoxicity for 0 and 10 wt% IO
nanogels were lower than the 5 wt% IO nanogels (p=3.04*10-4 and p=0.03 respectively), and the
15 wt% IO nanogels were the least cytotoxic at 0.31 mg·ml-1 concentrations (p=0.02, p=0.02,
and p=0.05 for 0, 5, and 10wt% nanogels). At 0.625 mg·ml-1, the 0 wt% IO nanogels had a
greater cell viability than the 5 wt% IO nanogels (p=2.00*10-6), and the 10 and 15 wt% IO
nanogels had larger cell viabilities than both the 0 and 5 wt% IO nanogels (p=0.002 and p=
8.24*10-4 respectively for 10 wt% IO nanogels; p=0.02 and 0.01 for 15 wt% IO nanogels).
The general trend of the data for the NDPLA nanogels shows a slight decrease in the
number of viable cells as the concentration of the nanogel increased viability from 0.31 mg·ml-1
to 10 mg·ml-1. The base NDPLA nanogel went below 80% cell viability when the nanogel
concentration in the well was 2.5 mg·ml-1. At that concentration, cell viability was found to be
around 79.24% (Figure 6). The 5 wt% IO NDPLA nanogel had comparable cytotoxicity to the
base nanogel from 0.625 mg·ml-1 to 10 mg·ml-1 indicating that iron oxide had no statistically
effects on cytotoxicity at that concentration. NDPCL nanogels also show a decline in cell
viability as the nanogel concentrations increase from 0.31 mg·ml-1 to 10 mg·ml-1 (Figure 7). The
base NDPCL nanogel dropped below 80% viability after a concentration of 0.31 mg·ml-1
indicating the NDPCL nanogel system is intrinsically more cytotoxic than NDPLA. The 5 wt%
IO NDPCL nanogel was found to be cytotoxic across all nanogel concentrations, and the 10 and
15 wt% NDPCL nanogels improved the cell viability from 0.31 mg·ml-1 to 0.625 mg·ml-1; 10
wt% showed an increase in cell viability at a concentration 2.5 mg·ml-1 as well. While there does
not seem to be a report in the literature that directly compares the cytotoxicity of PLA and PCL
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nanogels/hydrogels, other papers using the dex-lactate-HEMA based system have observed
different trends in cytotoxicity. Damera et al. and Janagam et al. have found that dextran-lactateHEMA hydrogels [70] and dextran-PLA-HEMA nanogels [69] are not cytotoxic below and at 15
mg·ml-1 for adipose derived stem cells (ADSC) and dental pulp stem cells (DPSC) [70] and 1
mg·ml-1 for human fetal retinal pigment epithelial (hfRPE) cells [69]. Janagam et al. also
incorporated acrylic acid in the dextran-PLA-HEMA nanogels and found that the nanogels were
not toxic to ? cells at concentration up to 1 mg·ml-1 which is less than the concentration range
evaluated in this paper (up to 10 mg·ml-1) [69]. The degradation products of the both the nanogel
and hydrogel systems were found to be non-cytotoxic for the NDPLA system, but an evaluation
of cytotoxicity for the NDPCL system has yet to be done.
When the iron oxide concentration increased to 10 wt% and 15 wt%, the nanogels
showed increased cell viability overall compared to the 0% IO nanogel, especially for the
NDPLA system, indicating that the higher iron oxide concentrations either stimulate growth or
protects the cells from damaging effects. Wang et al., Sandhya et al., and Delcroix et al. all
found that iron oxide nanoparticles loaded into nanogels can be cytotoxic at high concentrations
(concentration-dependent toxicity) and had little impact on proliferation at low concentrations
for osteoblasts [71], fibroblasts [72], and neural stem cells [73] at concentrations of 16.7 wt%
[71], 25 to 100 µg·ml-1 [72], and under 50 µg·ml-1 [73]. This suggests that iron oxide
nanoparticles do not stimulate growth and have the potential to induce increased cytotoxicity if
loaded in high concentrations. Pareta et al., Le et al., and Huang et al., however, have found that
iron oxide nanoparticles have the potential to reduce intracellular hydrogen peroxide and free
radical levels similar to an antioxidant allowing for the proliferation of bone [74], fibroblasts
[75], and mesenchymal stem cells [76]. These studies found that iron oxide helps to prevent cell
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death in cells that are undergoing peroxidase activity due to environment and internal cellular
mechanisms. If the nanogels were not properly purified after the synthesis step or incomplete
polymerization occurred, unconjugated starting material would be present in the nanogel systems
and subsequently increase the overall cytotoxicity. As the cytotoxicity for NDPLA and NPCL
nanogels was lower than expected when compared to similar systems, improper purification is a
probable cause and needs to be investigated in the future. It is possible that the iron oxide acted
as an oxygen scavenger and protected against any reactive oxygen species or free radicals that
happened to be present as the nanogels degraded, leading to net rises in cell viability. However,
this hypothesis needs to be tested in the future.
While there were indications of statistical significance indicated by graphs and the MannWhitney U Tests, caution should be taken as the sample size for the nanogels is small. To more
positively determine if the samples evaluated are statistically different, the experiment should be
run with a larger sample size. Generally, however, there is a positive increase in cell viability
between 5% IO and 10% for NDPLA nanogels. Also, as the nanogel concentration increased,
there is a decrease in cell viability. For NDPCL nanogels, there is a lot of variance in the
measurements, but there is less cell viability as the nanogel concentration increases.
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Figure 5: Cell viabilities for the NDPLA nanogels (0 to 15 wt% IO) as the administered nanogel
concentrations increased from 0.3125 to 10 mg·ml-1. Error bars indicate the standard deviation of
the cell viability for each of the wt% IO NDPLA nanogels at the loaded nanogel concentration.
The lines indicate the relationship between the nanogels. One star above a line is p<0.05, and
two stars indicate p<0.01. For 0 wt% IO NDPLA, n=5 and n=2 for 5, 10, and 15 wt% IO
NDPLA nanogels.
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Figure 6: The cell viabilities for the NDPCL nanogels (0 to 15 wt% IO) as the administered
nanogel concentrations increased from 0.3125 to 10 mg·ml-1. Error bars indicate the standard
deviation of the cell viability for each of the wt% IO NDPCL nanogels at the loaded nanogel
concentration. The lines indicate the relationship between the nanogels. One star above a line is
p<0.05, and two stars indicate p<0.01. For 0 wt% IO NDPCL, n=5 and n=2 for 5, 10, and 15
wt% IO NDPCL nanogels.

Conclusion
Iron oxide was successfully incorporated into dextran-lactate-HEMA nanogel systems
during nanogel synthesis. Both Dextran-PCL-HEMA and Dextran-PLA-HEMA nanogels loaded
with magnetic nanoparticles are capable of responding to external magnetic fields. NDPLA and
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NPCL nanogels alone had inherent ferromagnetic responsiveness, which can then be increased
by encapsulating iron oxide nanoparticles. The NDPCL nanogels have higher saturation
magnetization than the NPLA nanogels for iron oxide concentrations at 0, 5, and 15 wt%,
making it more appropriate for targeting and stimuli-controlled release.
Despite the lower magnetic responsiveness, the NDPLA nanogels are less cytotoxic than
NDPCL nanogels. The lower cell viabilities for the NDPCL nanogels indicate that the system's
cytotoxic response must be overcome. For both systems, increases in nanogel concentrations lead
to a reduction of cell viability. With NDPLA nanogels, the 10 and 15 wt% iron oxide lead to
improvements in cell viability for the nanogel system. NDPCL nanogels saw a similar increase
but on a much smaller scale. Limitations for this study include small sample sizes and a limited
number of properties evaluated. Nanogels that use iron oxide nanoparticles can be used in
various clinical applications. Drug delivery across biological barriers, thermal ablation of cancer
cells, imaging contrasts, and controlled and sustained release are examples of applications
systems like NDPLA and NDPCL nanogels can be used for. When compared together, the
NDPLA system is the better option than NDPCL due to the lower cytotoxicity even though the
saturation magnetization is smaller.
Future Work
The ferromagnetic property can be helpful in generating energy in uses like hyperthermia
and diagnostic situations like MRI imaging and is still useful in targeting via an external
magnetic field. Future studies will include measuring the size of the nanogel by using light
scattering, atomic force microscope, and transmission electron microscope. Optimization of the
nanogel will be done by changing the composition of the nanogels including the length of
lactate/caprolactone space in the dextran macromers, the weight ratios between NIPAAM
19

monomer and dextran macromer, and iron oxide content. Furthermore, more tests need to be
performed to determine the cytotoxicity of the magnetic nanogels to a variety of cell lines, and
the effects of magnetic field on the magnetic nanogels to control release of drugs across in vitro
and ex vivo biological barriers. Finally, animal studies are also needed to evaluate the toxicology
and biological effects of the magnetic nanogels in vivo.
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